MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. TSX:LABS OTCQB:MEDIF FSE:MLZ ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three and nine months ended September 30…